Search

Eyewire News: The Podcast

Eyewire News: The Podcast

11.20.24

Lumithera CEO Discusses FDA Authorization for Veleda for Dry AMD

The CEO of Lumithera joins us to discuss the FDA authorization of the Veleda system for dry AMD; the FDA accepts the resubmitted NDA for dry eye disease candidate reproxalap; and Alcon launches the first contact lens designed for a 1-week replacement cycle.

View full description +

MORE EPISODES

09.03.25

Update on Investigational Treatments for Retinal Diseases

08.27.25

CE Certification for New Glaucoma Surgical Implant

08.20.25

Special Report: TFOS DEWS III Leaders Discuss New DED Guidance

08.13.25

First Commerical Surgeries Performed with MacTel Therapy

08.06.25

Alcon Acquires Staar for $1.5 Billion

07.30.25

Tryptyr Now Available in US

07.23.25

Harrow Adds Biosimilars to US Portfolio

07.16.25

AECOS Presentation Summaries

Show More

Anterior 3D Cataract Cornea General Glaucoma Optometry Pediatric Refractive/LVC Residents & Fellows Retina Retina 3D